DE60044690D1 - Verfahren zur Herstellung von rekombinanten Proteinen mittels Inhibitoren von Apoptose - Google Patents
Verfahren zur Herstellung von rekombinanten Proteinen mittels Inhibitoren von ApoptoseInfo
- Publication number
- DE60044690D1 DE60044690D1 DE60044690T DE60044690T DE60044690D1 DE 60044690 D1 DE60044690 D1 DE 60044690D1 DE 60044690 T DE60044690 T DE 60044690T DE 60044690 T DE60044690 T DE 60044690T DE 60044690 D1 DE60044690 D1 DE 60044690D1
- Authority
- DE
- Germany
- Prior art keywords
- apoptosis
- inhibitors
- recombinant proteins
- production
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/92—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15623299P | 1999-09-27 | 1999-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60044690D1 true DE60044690D1 (de) | 2010-08-26 |
Family
ID=22558684
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60044690T Expired - Lifetime DE60044690D1 (de) | 1999-09-27 | 2000-09-25 | Verfahren zur Herstellung von rekombinanten Proteinen mittels Inhibitoren von Apoptose |
DE60025015T Expired - Lifetime DE60025015T2 (de) | 1999-09-27 | 2000-09-25 | Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60025015T Expired - Lifetime DE60025015T2 (de) | 1999-09-27 | 2000-09-25 | Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose |
Country Status (13)
Country | Link |
---|---|
US (4) | US6586206B1 (de) |
EP (2) | EP1650307B1 (de) |
JP (1) | JP2003510087A (de) |
AT (2) | ATE474052T1 (de) |
AU (1) | AU7614600A (de) |
CA (1) | CA2384880C (de) |
DE (2) | DE60044690D1 (de) |
DK (2) | DK1220934T3 (de) |
ES (2) | ES2254230T3 (de) |
HK (1) | HK1091228A1 (de) |
IL (2) | IL148512A0 (de) |
PT (1) | PT1650307E (de) |
WO (1) | WO2001023592A2 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7614600A (en) * | 1999-09-27 | 2001-04-30 | Genentech Inc. | Methods for making recombinant proteins using apoptosis inhibitors |
US7405038B1 (en) | 2000-03-03 | 2008-07-29 | Boyce Thompson Institute For Plant Research, Inc. | Stable cell lines resistant to apoptosis and nutrient stress and methods of making same |
EP1414948B1 (de) * | 2001-07-10 | 2009-09-16 | Biogen Idec Inc. | Hemmung des apoptoseprozesses und verbesserung der zelleistung |
KR100454016B1 (ko) * | 2002-01-05 | 2004-10-26 | 한국과학기술원 | 항예정사 유전자로 형질전환되고 dhfr 유전자가결핍된 신규한 cho 세포주, 그의 제조 방법 및 상기형질전환된 cho 숙주 세포를 이용한 목적단백질의 생산방법 |
EP1676911B1 (de) * | 2003-10-24 | 2010-04-21 | Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute | Neue rekombinante tierzellen mit hoher proteinproduktion, verfahren zur konstruktion davon sowie verfahren zur massenproduktion von protein unter verwendung davon |
US7531327B2 (en) * | 2004-07-23 | 2009-05-12 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
AU2005333513B2 (en) * | 2004-07-23 | 2011-06-02 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
US7537930B2 (en) | 2004-07-23 | 2009-05-26 | Immunomedics, Inc. | Mammalian cell lines for increasing longevity and protein yield from a cell culture |
US7608425B2 (en) * | 2004-07-23 | 2009-10-27 | Immunomedics, Inc. | Methods for protein expression in mammalian cells in serum-free medium |
CA2576464C (en) * | 2004-07-23 | 2014-09-09 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
CA2579677A1 (en) * | 2004-09-16 | 2006-03-30 | Sangamo Biosciences, Inc. | Compositions and methods for protein production |
KR20070082597A (ko) * | 2004-12-30 | 2007-08-21 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 유전자 |
US20060263809A1 (en) * | 2005-04-05 | 2006-11-23 | The Rgents Of The University Of California | Method for sensitive measure of low level apoptosis in cells |
US20070092947A1 (en) * | 2005-10-20 | 2007-04-26 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
SG10201510384UA (en) | 2006-09-13 | 2016-01-28 | Abbvie Inc | Cell culture improvements |
US8273722B2 (en) * | 2007-07-13 | 2012-09-25 | Dharmacon, Inc. | Enhanced biotherapeutic production using inhibitory RNA |
JP5283044B2 (ja) * | 2007-10-09 | 2013-09-04 | 国立大学法人広島大学 | 目的遺伝子を染色体外で高度に増幅させるためのベクターおよびその利用 |
CN101952303A (zh) | 2008-02-25 | 2011-01-19 | 诺维信公司 | 提高目标蛋白质的表达产率的方法 |
US20100049284A1 (en) * | 2008-05-15 | 2010-02-25 | The Catholic University Of America | Use of heat to treat biological systems exposed to damaging radiation |
MX2011002638A (es) | 2008-09-15 | 2011-04-05 | Genentech Inc | Composiciones y metodos para regular osmolaridad celular. |
AU2009347206C1 (en) | 2008-10-20 | 2016-12-08 | Abbvie Inc. | Isolation and purification of antibodies using Protein A affinity chromatography |
CA2738499A1 (en) | 2008-10-20 | 2010-04-29 | Abbott Laboratories | Viral inactivation during purification of antibodies |
EP2398896A4 (de) | 2009-02-20 | 2013-02-20 | Ventria Bioscience | Zellkulturmedien mit kombinationen aus proteinen |
EP2702077A2 (de) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen |
WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
WO2014022102A1 (en) * | 2012-08-01 | 2014-02-06 | Amgen Inc. | Methods of using anti-apoptotic compounds to modulate one or more properties of a cell culture |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
US9206390B2 (en) | 2012-09-02 | 2015-12-08 | Abbvie, Inc. | Methods to control protein heterogeneity |
CA2905010A1 (en) | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
DE102013206438A1 (de) | 2013-04-11 | 2014-10-16 | Bühler Motor GmbH | Permanentmagnetrotor für einen elektronisch kommutierten Gleichstrommotor |
CN113801895A (zh) | 2013-09-23 | 2021-12-17 | 威尔逊沃夫制造公司 | 遗传修饰动物细胞的改进方法 |
EP3052640A2 (de) | 2013-10-04 | 2016-08-10 | AbbVie Inc. | Verwendung von metallionen zur modulation von proteinglykosylierungsprofilen rekombinanter proteine |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
WO2015073884A2 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
ES2825574T3 (es) * | 2014-07-09 | 2021-05-17 | Hoffmann La Roche | Ajuste del pH para mejorar la recuperación por descongelación de bancos de células |
EP3277823B1 (de) * | 2015-04-03 | 2023-09-13 | Dana-Farber Cancer Institute, Inc. | Zusammensetzung und verfahren zur genomänderung von b-zellen |
CN111349615B (zh) * | 2018-12-24 | 2024-08-13 | 上海细胞治疗集团股份有限公司 | 制备过表达外源基因的细胞的方法 |
CN112080439B (zh) * | 2020-07-30 | 2023-01-10 | 浙江工业大学 | 人源细胞凋亡调控蛋白Bcl-2在提高酿酒酵母橙花叔醇产量中的应用 |
WO2022036232A2 (en) * | 2020-08-14 | 2022-02-17 | Bristol-Myers Squibb Company | Method of making protein |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2971218B2 (ja) * | 1991-12-04 | 1999-11-02 | 協和醗酵工業株式会社 | ウリカーゼ遺伝子およびウリカーゼの製造法 |
GB9202796D0 (en) | 1992-02-11 | 1992-03-25 | Wellcome Found | Antiviral antibody |
JPH09163983A (ja) * | 1995-08-30 | 1997-06-24 | Hisamitsu Pharmaceut Co Inc | アポトーシス抑制による有用物質の効率的生産方法および細胞 |
FR2749022B1 (fr) | 1996-05-23 | 2001-06-01 | Rhone Merieux | Cellules aviaires immortelles |
FR2749021B1 (fr) | 1996-05-23 | 2001-10-26 | Agronomique Inst Nat Rech | Lignees de cellules aviaires immortalisees |
US5876923A (en) * | 1996-07-26 | 1999-03-02 | Arch Development Corporation | Herpes simplex virus ICP4 as an inhibitor of apoptosis |
JP3830976B2 (ja) | 1996-09-12 | 2006-10-11 | アイドゥン ファーマシューティカルズ,インコーポレイテッド | インターロイキン―1β―転換酵素(ICE)/CED―3ファミリーインヒビターを用いたアポトーシスの阻害 |
US6072047A (en) | 1997-02-13 | 2000-06-06 | Immunex Corporation | Receptor that binds trail |
US6855544B1 (en) * | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
ATE366803T1 (de) * | 1999-09-08 | 2007-08-15 | Genetrol Biotherapeutics | Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit |
AU7614600A (en) * | 1999-09-27 | 2001-04-30 | Genentech Inc. | Methods for making recombinant proteins using apoptosis inhibitors |
-
2000
- 2000-09-25 AU AU76146/00A patent/AU7614600A/en not_active Abandoned
- 2000-09-25 ES ES00965426T patent/ES2254230T3/es not_active Expired - Lifetime
- 2000-09-25 DK DK00965426T patent/DK1220934T3/da active
- 2000-09-25 DE DE60044690T patent/DE60044690D1/de not_active Expired - Lifetime
- 2000-09-25 DE DE60025015T patent/DE60025015T2/de not_active Expired - Lifetime
- 2000-09-25 EP EP05020550A patent/EP1650307B1/de not_active Expired - Lifetime
- 2000-09-25 US US09/668,924 patent/US6586206B1/en not_active Expired - Lifetime
- 2000-09-25 IL IL14851200A patent/IL148512A0/xx unknown
- 2000-09-25 ES ES05020550T patent/ES2346659T3/es not_active Expired - Lifetime
- 2000-09-25 WO PCT/US2000/026352 patent/WO2001023592A2/en active IP Right Grant
- 2000-09-25 AT AT05020550T patent/ATE474052T1/de active
- 2000-09-25 JP JP2001526974A patent/JP2003510087A/ja active Pending
- 2000-09-25 PT PT05020550T patent/PT1650307E/pt unknown
- 2000-09-25 AT AT00965426T patent/ATE313634T1/de active
- 2000-09-25 CA CA2384880A patent/CA2384880C/en not_active Expired - Lifetime
- 2000-09-25 DK DK05020550.9T patent/DK1650307T3/da active
- 2000-09-25 EP EP00965426A patent/EP1220934B1/de not_active Expired - Lifetime
-
2002
- 2002-03-05 IL IL148512A patent/IL148512A/en active IP Right Grant
-
2003
- 2003-06-27 US US10/607,882 patent/US20040002139A1/en not_active Abandoned
-
2006
- 2006-06-15 US US11/454,670 patent/US20070004009A1/en not_active Abandoned
- 2006-10-06 HK HK06111038.5A patent/HK1091228A1/xx unknown
-
2009
- 2009-11-30 US US12/592,606 patent/US20100087624A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1650307A2 (de) | 2006-04-26 |
DE60025015D1 (de) | 2006-01-26 |
DE60025015T2 (de) | 2006-08-03 |
DK1650307T3 (da) | 2010-10-04 |
ATE313634T1 (de) | 2006-01-15 |
EP1650307A3 (de) | 2006-05-03 |
IL148512A (en) | 2011-04-28 |
ES2254230T3 (es) | 2006-06-16 |
EP1220934A2 (de) | 2002-07-10 |
CA2384880A1 (en) | 2001-04-05 |
WO2001023592A2 (en) | 2001-04-05 |
US20100087624A1 (en) | 2010-04-08 |
CA2384880C (en) | 2010-09-21 |
EP1650307B1 (de) | 2010-07-14 |
DK1220934T3 (da) | 2006-05-08 |
JP2003510087A (ja) | 2003-03-18 |
HK1091228A1 (en) | 2007-01-12 |
WO2001023592A3 (en) | 2001-12-20 |
ATE474052T1 (de) | 2010-07-15 |
US6586206B1 (en) | 2003-07-01 |
EP1220934B1 (de) | 2005-12-21 |
PT1650307E (pt) | 2010-10-21 |
US20070004009A1 (en) | 2007-01-04 |
IL148512A0 (en) | 2002-09-12 |
AU7614600A (en) | 2001-04-30 |
ES2346659T3 (es) | 2010-10-19 |
US20040002139A1 (en) | 2004-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60044690D1 (de) | Verfahren zur Herstellung von rekombinanten Proteinen mittels Inhibitoren von Apoptose | |
ATE405644T1 (de) | Verfahren zur herstellung und reinigung von erythropoietin | |
DE60216959D1 (de) | Sich in schlagende kardiomyozyten verwandelnde stammzellen | |
DE59912118D1 (de) | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen | |
DK0917571T3 (da) | Hidtil ukendt agoutirelateret gen | |
DE59608743D1 (de) | Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation | |
DK1218509T3 (da) | Fibroblast vækstfaktorlignende polypeptider | |
DE502004008542D1 (de) | Verfahren zur reklonierung von produktionszellen | |
BR8301918A (pt) | Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase | |
BR0214029A (pt) | Métodos e composições para o uso de células estromais para suportar células tronco embriÈnicas e adultas | |
ATE407138T1 (de) | Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle | |
DE10390418D2 (de) | Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen | |
ATE309353T1 (de) | Verfahren zur herstellung von rekombinanten peptiden | |
ATE421574T1 (de) | Zellkulturmethode zur erzeugung von prostata- ähnlichen acini | |
ATE414141T1 (de) | Verfahren zur kultivierung humaner chondrozyten | |
DE69909909D1 (de) | Verfahren zur Herstellung von Erythritol mittels wiederholten fedbatch Fermentation | |
DE69939876D1 (de) | Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren | |
DE69419592D1 (de) | Verfahren zur Herstellung von Pilocarpin | |
DE69521281D1 (de) | Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA. | |
ATE313622T1 (de) | Verfahren zur züchtung von haftenden tierischen zellen | |
DE50011342D1 (de) | Polycarbonat-substrate | |
ATE127527T1 (de) | Verfahren zur herstellung eines metastaseninhibitorenfaktors. | |
ATE288476T1 (de) | Herstellung von proteinen | |
DE69834900D1 (de) | Verfahren zur Herstellung von Zellkulturen |